BRIEF published on 05/07/2026 at 18:05, 10 days 5 hours ago Publication of Voting Rights by BOIRON as of April 30, 2026 Share Capital Voting Rights AMF BOIRON 2026
BRIEF published on 04/29/2026 at 14:05, 18 days 9 hours ago Provision of documents for the Boiron General Meeting Shareholders General Assembly Preparatory Documents BOIRON BALO
BRIEF published on 04/22/2026 at 15:35, 25 days 8 hours ago Availability of BOIRON's 2025 Annual Financial Report Investors AMF Annual Accounts BOIRON Financial Report 2025
BRIEF published on 04/09/2026 at 17:05, 1 month 8 days ago Publication of BOIRON's Voting Rights as of March 31, 2026 Share Capital Voting Rights AMF Financial Publication BOIRON Shares
BRIEF published on 04/02/2026 at 17:50, 1 month 15 days ago BOIRON Laboratories 2025 Financial Results Revenue Dividend BOIRON 2025 Results Integrative Health
BRIEF published on 03/04/2026 at 14:15, 2 months 13 days ago Publication of BOIRON's voting rights as of February 28, 2026 Share Capital Voting Rights Actions AMF BOIRON
BRIEF published on 02/24/2026 at 08:50, 2 months 21 days ago Boiron and Panaxia join forces in medical cannabis Europe Partnership Medical Cannabis BOIRON Panaxia Malta
BRIEF published on 02/10/2026 at 10:45, 3 months 7 days ago BOIRON: Declaration of Voting Rights as of January 31, 2026 Share Capital Voting Rights Actions AMF BOIRON
BRIEF published on 01/14/2026 at 10:50, 4 months 3 days ago BOIRON: Eligibility for PEA-PME Confirmed PEA-PME Investors Market Capitalization Eligibility BOIRON
BRIEF published on 01/09/2026 at 16:35, 4 months 8 days ago Publication of Boiron's voting rights as of December 31, 2025 Voting Rights Capital Actions AMF BOIRON
Published on 05/16/2026 at 01:15, 1 day 22 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 23 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 days ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 7 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 3 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 5 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 2 days 6 hours ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 2 days 8 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 17:45, 4 days 5 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 4 days 5 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 4 days 5 hours ago Report on share repurchases from 6 to 12 May 2026
